Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Dominique P. Germain et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedureMinke H. de Ru, Frits A. Wijburg, Jaap Jan Boelens et al.|Orphanet Journal of Rare Diseases|2011Cited by 233
Multidisciplinary Management of Hunter SyndromeJoseph Muenzer, Ed Wraith, Michael Beck et al.|PEDIATRICS|2009Cited by 193
GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findingsAnna Caciotti, Amelia Morrone, Scott C. Garman et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2011Cited by 157